Home/Filings/4/0001209191-21-047290
4//SEC Filing

Huggenberger Raymond 4

Accession 0001209191-21-047290

CIK 0001294133other

Filed

Jul 18, 8:00 PM ET

Accepted

Jul 19, 8:26 PM ET

Size

10.7 KB

Accession

0001209191-21-047290

Insider Transaction Report

Form 4
Period: 2021-07-15
Huggenberger Raymond
DirectorSee Remarks
Transactions
  • Sale

    Common Stock

    2021-07-15$65.81/sh6,822$448,96317,761 total
  • Exercise/Conversion

    Common Stock

    2021-07-15$38.54/sh+4,000$154,16024,583 total
  • Sale

    Common Stock

    2021-07-15$66.62/sh178$11,85817,583 total
  • Exercise/Conversion

    Stock Option (Right to Buy)

    2021-07-154,00019,806 total
    Exercise: $38.54Exp: 2022-05-15Common Stock (4,000 underlying)
Footnotes (3)
  • [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 1, 2021.
  • [F2]Represents the weighted average share price of an aggregate total of 6,822 shares sold in the price range of $65.258 to $66.23 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
  • [F3]Represents the share price of an aggregate total of 178 shares sold at a price of $66.62 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

Issuer

Inogen Inc

CIK 0001294133

Entity typeother

Related Parties

1
  • filerCIK 0001596078

Filing Metadata

Form type
4
Filed
Jul 18, 8:00 PM ET
Accepted
Jul 19, 8:26 PM ET
Size
10.7 KB